Replies to post #74141 on Innovation Pharmaceuticals Inc (IPIX)

[noretreat]

I don't expect any public info on buyout or partnership until 2015 at the earliest. There are too many pending results that can significantly multiply (or shave) market cap.

[BonelessCat]

If K shows miracles in the Phase 1 trial (tumor shrinkage/remission in 2 or more types of stage 3-4 cancers), early work in the MD Anderson and UoB trials shows miracles (effective cures for AML and that other thing), and by miracle B-ABSSSI surpasses Dapto (1 day, >93% efficacy), and OM and foot odor are equally miraculous (prevents and treats tissue lesions), expect a buyout price well above $500 a share.

Only saying the above outcomes are possible considering preclinical work and known current clinical outcomes.

Those of you who have been here more than 18 months will recall my valuations in the $35 billion range, and that was without B. At some point I will do a new valuation study based on updating the pipeline and the latest and most recent big pharma deals.

I don't like to do CTIX high end valuations because the high altitudes give me nose bleeds.